182 related articles for article (PubMed ID: 4065947)
21. The c-myc promoter: still MysterY and challenge.
Wierstra I; Alves J
Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
[TBL] [Abstract][Full Text] [Related]
23. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
[TBL] [Abstract][Full Text] [Related]
24. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.
Adams JM; Gerondakis S; Webb E; Corcoran LM; Cory S
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1982-6. PubMed ID: 6572957
[TBL] [Abstract][Full Text] [Related]
25. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal translocations in B-cell derived tumors.
Klein G
Princess Takamatsu Symp; 1986; 17():159-70. PubMed ID: 3332008
[TBL] [Abstract][Full Text] [Related]
27. The effect of translocations on the cellular myc gene in Burkitt lymphomas.
Mitchell KF; Battey J; Hollis GF; Moulding C; Taub R; Leder P
J Cell Physiol Suppl; 1984; 3():171-7. PubMed ID: 6378935
[TBL] [Abstract][Full Text] [Related]
28. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
30. Oncogene probes in the detection of human cancer.
Showe LC; Croce CM
Clin Physiol Biochem; 1987; 5(3-4):227-37. PubMed ID: 3621798
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma.
ar-Rushdi A; Nishikura K; Erikson J; Watt R; Rovera G; Croce CM
Science; 1983 Oct; 222(4622):390-3. PubMed ID: 6414084
[TBL] [Abstract][Full Text] [Related]
32. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
Gutsch DE; Marcu KB; Kenney SC
Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
[TBL] [Abstract][Full Text] [Related]
33. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
Mautner J; Behrends U; Hörtnagel K; Brielmeier M; Hammerschmidt W; Strobl L; Bornkamm GW; Polack A
Oncogene; 1996 Mar; 12(6):1299-307. PubMed ID: 8649832
[TBL] [Abstract][Full Text] [Related]
34. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.
Croce CM; Erikson J; ar-Rushdi A; Aden D; Nishikura K
Proc Natl Acad Sci U S A; 1984 May; 81(10):3170-4. PubMed ID: 6328505
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal translocations, immunoglobulin genes, and oncogenes in human B-cell tumors.
Nowell PC; Erikson J; Finan J; Emanuel B; Croce CM
Prog Clin Biol Res; 1985; 184():457-68. PubMed ID: 3931093
[No Abstract] [Full Text] [Related]
36. A variant translocation places the lambda immunoglobulin genes 3' to the c-myc oncogene in Burkitt's lymphoma.
Hollis GF; Mitchell KF; Battey J; Potter H; Taub R; Lenoir GM; Leder P
Nature; 1984 Feb 23-29; 307(5953):752-5. PubMed ID: 6422306
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma.
Erikson J; ar-Rushdi A; Drwinga HL; Nowell PC; Croce CM
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):820-4. PubMed ID: 6402776
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt.
Croce CM; Thierfelder W; Erikson J; Nishikura K; Finan J; Lenoir GM; Nowell PC
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6922-6. PubMed ID: 6417658
[TBL] [Abstract][Full Text] [Related]
39. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma.
Rabbitts TH; Forster A; Baer R; Hamlyn PH
Nature; 1983 Dec 22-1984 Jan 4; 306(5945):806-9. PubMed ID: 6419124
[TBL] [Abstract][Full Text] [Related]
40. [Burkitt's lymphoma in 1985].
Philip T; Lenoir GM; Favrot M; Philip I; Brunat-Mentigny M
Pediatrie; 1985 Mar; 40(2):137-60. PubMed ID: 3001632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
